
    
      Postmarketing Observational Study to Evaluate the Work Productivity, Safety and Efficacy of
      Humira for the Treatment of Moderate to Severe Plaque Psoriasis in Daily Clinical Practice.
      The primary objectives of the PMOS are to explore changes in health related care utilization
      data by the evaluation of:

        -  the number of missed working days

        -  the number of visits to doctor's office

        -  the number and duration of hospitalizations

        -  work ability to assess efficacy for different subgroups by

        -  the number of patients achieving a PASI 75 response to evaluate safety by

        -  the documentation and analysis of adverse events for all patients and subgroups with
           concomitant diseases Secondary objectives include the exploration of changes in quality
           of life measurements, of the influence of age, gender and duration of disease
    
  